1-9 of 9
Johannes A. Romijn
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Hepatic Insulin Resistance Is Not Pathway Selective in Humans With Nonalcoholic Fatty Liver Disease

Kasper W. ter Horst, Daniel F. Vatner, Dongyan Zhang, Gary W. Cline, Mariette T. Ackermans, Aart J. Nederveen, Joanne Verheij, Ahmet Demirkiran, Bart A. van Wagensveld, Geesje M. Dallinga-Thie, Max Nieuwdorp, Johannes A. Romijn, Gerald I. Shulman, Mireille J. Serlie
Journal: Diabetes Care
Diabetes Care 2021;44(2):489–498
https://doi.org/10.2337/dc20-1644
Published: 08 December 2020
View article titled, Hepatic Insulin Resistance Is Not Pathway Selective in Humans With Nonalcoholic Fatty Liver Disease
Open the PDF for Hepatic Insulin Resistance Is Not Pathway Selective in Humans With Nonalcoholic Fatty Liver Disease in another window
Journal Articles

Very-Low-Calorie Diet Increases Myocardial Triglyceride Content and Decreases Diastolic Left Ventricular Function in Type 2 Diabetes With Cardiac Complications

Jacqueline T. Jonker, Roxana Djaberi, Linda D. van Schinkel, Sebastiaan Hammer, Mieke T.J. Bus, Gijs Kerpershoek, Aan V. Kharagjitsingh, Johannes A. Romijn, Jeroen J. Bax, J. Wouter Jukema, Albert de Roos, Johannes W.A. Smit, Hildo J. Lamb
Journal: Diabetes Care
Diabetes Care 2014;37(1):e1–e2
https://doi.org/10.2337/dc13-1423
Published: 11 December 2013
View article titled, Very-Low-Calorie Diet Increases Myocardial Triglyceride Content and Decreases Diastolic Left Ventricular Function in Type 2 Diabetes With Cardiac Complications
Open the PDF for Very-Low-Calorie Diet Increases Myocardial Triglyceride Content and Decreases Diastolic Left Ventricular Function in Type 2 Diabetes With Cardiac Complications in another window
Journal Articles

Prolonged Caloric Restriction in Obese Patients With Type 2 Diabetes Mellitus Decreases Plasma CETP and Increases Apolipoprotein AI Levels Without Improving the Cholesterol Efflux Properties of HDL

Yanan Wang, MSC, Marieke Snel, MD, Jacqueline T. Jonker, MD, Sebastiaan Hammer, MD, Hildo J. Lamb, MD, Albert de Roos, MD, A. Edo Meinders, MD, Hanno Pijl, MD, Johannes A. Romijn, MD, Johannes W.A. Smit, MD, Ingrid M. Jazet, MD, Patrick C.N. Rensen, PHD
Journal: Diabetes Care
Diabetes Care 2011;34(12):2576–2580
https://doi.org/10.2337/dc11-0685
Published: 14 November 2011
View article titled, Prolonged Caloric Restriction in Obese Patients With Type 2 Diabetes Mellitus Decreases Plasma CETP and Increases Apolipoprotein AI Levels Without Improving the Cholesterol Efflux Properties of HDL
Open the PDF for Prolonged Caloric Restriction in Obese Patients With Type 2 Diabetes Mellitus Decreases Plasma CETP and Increases Apolipoprotein AI Levels Without Improving the Cholesterol Efflux Properties of HDL in another window
Includes: Supplementary data
Journal Articles

Partial Sleep Restriction Decreases Insulin Sensitivity in Type 1 Diabetes

Esther Donga, MD, Marieke van Dijk, MD, J. Gert van Dijk, MD, PHD, Nienke R. Biermasz, MD, PHD, Gert-Jan Lammers, MD, PHD, Klaas van Kralingen, MD, PHD, Roel P.L.M. Hoogma, MD, PHD, Eleonora P.M. Corssmit, MD, PHD, Johannes A. Romijn, MD, PHD
Journal: Diabetes Care
Diabetes Care 2010;33(7):1573–1577
https://doi.org/10.2337/dc09-2317
Published: 31 March 2010
View article titled, Partial Sleep Restriction Decreases Insulin Sensitivity in Type 1 Diabetes
Open the PDF for Partial Sleep Restriction Decreases Insulin Sensitivity in Type 1 Diabetes in another window
Journal Articles

Pioglitazone Decreases Plasma Cholesteryl Ester Transfer Protein Mass, Associated With a Decrease in Hepatic Triglyceride Content, in Patients With Type 2 Diabetes

Jacqueline T. Jonker, MD, Yanan Wang, MSC, Willeke de Haan, PHD, Michaela Diamant, MD, PHD, Luuk J. Rijzewijk, MD, Rutger W. van der Meer, MD, PHD, Hildo J. Lamb, MD, PHD, Jouke T. Tamsma, MD, PHD, Albert de Roos, MD, PHD, Johannes A. Romijn, MD, PHD, Patrick C.N. Rensen, PHD, Johannes W.A. Smit, MD, PHD
Journal: Diabetes Care
Diabetes Care 2010;33(7):1625–1628
https://doi.org/10.2337/dc09-1935
Published: 11 February 2010
View article titled, Pioglitazone Decreases Plasma Cholesteryl Ester Transfer Protein Mass, Associated With a Decrease in Hepatic Triglyceride Content, in Patients With Type 2 Diabetes
Open the PDF for Pioglitazone Decreases Plasma Cholesteryl Ester Transfer Protein Mass, Associated With a Decrease in Hepatic Triglyceride Content, in Patients With Type 2 Diabetes in another window
Journal Articles

Differences in Atherosclerotic Plaque Burden and Morphology Between Type 1 and 2 Diabetes as Assessed by Multislice Computed Tomography

Roxana Djaberi, MD, Joanne D. Schuijf, PHD, Eric Boersma, PHD, Lucia J.M. Kroft, MD, PHD, Alberto M. Pereira, MD, PHD, Johannes A. Romijn, MD, PHD, Arthur J. Scholte, MD, J. Wouter Jukema, MD, PHD, Jeroen J. Bax, MD, PHD
Journal: Diabetes Care
Diabetes Care 2009;32(8):1507–1512
https://doi.org/10.2337/dc09-0320
Published: 01 June 2009
View article titled, Differences in Atherosclerotic Plaque Burden and Morphology Between Type 1 and 2 Diabetes as Assessed by Multislice Computed Tomography
Open the PDF for Differences in Atherosclerotic Plaque Burden and Morphology Between Type 1 and 2 Diabetes as Assessed by Multislice Computed Tomography in another window
Journal Articles

Plasma Apolipoprotein CI and CIII Levels Are Associated With Increased Plasma Triglyceride Levels and Decreased Fat Mass in Men With the Metabolic Syndrome

Rachel L.M. van der Ham, MD, Reza Alizadeh Dehnavi, MD, Jimmy F.P. Berbée, PHD, Hein Putter, PHD, Albert de Roos, MD, PHD, Johannes A. Romijn, MD, PHD, Patrick C.N. Rensen, PHD, Jouke T. Tamsma, MD, PHD
Journal: Diabetes Care
Diabetes Care 2009;32(1):184–186
https://doi.org/10.2337/dc08-1330
Published: 01 January 2009
View article titled, Plasma Apolipoprotein CI and CIII Levels Are Associated With Increased Plasma Triglyceride Levels and Decreased Fat Mass in Men With the Metabolic Syndrome
Open the PDF for Plasma Apolipoprotein CI and CIII Levels Are Associated With Increased Plasma Triglyceride Levels and Decreased Fat Mass in Men With the Metabolic Syndrome in another window
Includes: Supplementary data
Journal Articles

Short-Term Hyperglycemic Dysregulation in Patients With Type 1 Diabetes Does Not Change Myocardial Triglyceride Content or Myocardial Function

Sebastiaan Hammer, MSC, Jacqueline T. Jonker, MD, Hildo J. Lamb, MD, PHD, Rutger W. van der Meer, MD, Wendy Zondag, MD, Jan M. Sepers, MD, PHD, Albert de Roos, MD, PHD, Johannes W.A. Smit, MD, PHD, Johannes A. Romijn, MD, PHD
Journal: Diabetes Care
Diabetes Care 2008;31(8):1613–1614
https://doi.org/10.2337/dc08-0513
Published: 01 August 2008
View article titled, Short-Term Hyperglycemic Dysregulation in Patients With Type 1 Diabetes Does Not Change Myocardial Triglyceride Content or Myocardial Function
Open the PDF for Short-Term Hyperglycemic Dysregulation in Patients With Type 1 Diabetes Does Not Change Myocardial Triglyceride Content or Myocardial Function in another window
Journal Articles

Steroids in Adult Men With Type 1 Diabetes: A tendency to hypogonadism

Eveline W.C.M. van Dam, MD, Jacqueline M. Dekker, PHD, Eef G.W.M. Lentjes, MD, PHD, Fred P.T.H.M. Romijn, Yvo M. Smulders, MD, PHD, Wendy J. Post, Johannes A. Romijn, MD, PHD, H. Michiel J. Krans, MD, PHD
Journal: Diabetes Care
Diabetes Care 2003;26(6):1812–1818
https://doi.org/10.2337/diacare.26.6.1812
Published: 01 June 2003
View article titled, Steroids in Adult Men With Type 1 Diabetes: <subtitle>A tendency to hypogonadism </subtitle>
Open the PDF for Steroids in Adult Men With Type 1 Diabetes: <subtitle>A tendency to hypogonadism </subtitle> in another window